The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma
about
The Evolving Nature of Hepatic Abscess: A ReviewQuality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial ChemoembolizationTranscatheter embolization therapy in liver cancer: an update of clinical evidencesComparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beadsImaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.CT findings of completely regressed hepatocellular carcinoma with main portal vein tumor thrombosis after transcatheter arterial chemoembolizationAdvanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.Design and rationale for the non-interventional Global Investigation of Therapeutic DEcisions in Hepatocellular Carcinoma and Of its Treatment with Sorafenib (GIDEON) study.Ectopic blood supply of hepatocellular carcinoma as depicted by angiography with computed tomography: associations with morphological features and therapeutic historyRole of radiotherapy in the management of hepatocellular carcinoma: A systematic review.Role of C-arm cone-beam CT in chemoembolization for hepatocellular carcinomaHepatocellular carcinomas smaller than 4 cm supplied by the intercostal artery: can we predict which intercostal artery supplies the tumor?Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies.Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patientsPredictors of hepatic decompensation after TACE for hepatocellular carcinomaPost-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinomaDoxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells.Hepatocellular carcinoma with blood supply from parasitized omental artery: angiographic appearance and chemoembolization.Chloroquine promotes the anticancer effect of TACE in a rabbit VX2 liver tumor model.Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma.Novel implications in the treatment of hepatocellular carcinoma.MDCT findings after hepatic chemoembolization with DC-beads: what the radiologist needs to know.Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1.Transarterial chemoembolization and sorafenib in hepatocellular carcinoma.Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.Association of hepatic vein Lipiodol tram-track sign during transcatheter arterial chemoembolization with perioperative death.Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway.Incorporation of ophiobolin a into novel chemoembolization particles for cancer cell treatment.Acute pancreatitis as a complication of trans-arterial chemoembolization of hepatocellular cancer-case report and review of literature.Chemoembolization via branches from the splenic artery in patients with hepatocellular carcinoma.Chemoembolization for hepatocellular carcinoma supplied by a lumbar artery.Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models.Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.Advances and Future Directions in the Treatment of Hepatocellular CarcinomaA Case of Cryptogenic Organizing Pneumonia after Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma.In vitro clearance of doxorubicin with a DNA-based filtration device designed for intravascular use with intra-arterial chemotherapy.The degree of hepatic arterial blood supply of portal vein tumor thrombus in patients with hepatocellular carcinoma and its impact on overall survival after transarterial chemoembolization.Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study.Hyaluronic acid-based nano-sized drug carrier-containing Gellan gum microspheres as potential multifunctional embolic agent.
P2860
Q26746451-995D11BA-5063-4A59-BCC2-9551A8F509D2Q26753024-9553B74A-46C0-4066-BEEE-C03EC7C6E54EQ27003849-869E8831-71C5-496C-B74F-DBD3ED542BA4Q28542950-FFF9A594-E501-40EA-A033-0243AE865643Q30458257-DDCF44FB-B059-4E8C-B2AD-2566D0914AE5Q33563785-CE8E5DF7-DC98-4454-B9AF-F443795A5A9EQ33797067-C6988197-9E9A-4ABF-A453-E83C82DB2FEDQ34001687-EC061FB9-2536-427F-BBF6-75D8D976DC56Q34964729-F6CE54F6-6FC1-4847-8884-68080CF2701FQ34966816-2D37732B-85C0-49C8-8E0D-6F8A303B0B44Q34975104-FBC619EF-9946-4AA2-BE8D-42C771F4C3B1Q35360925-295E6CC2-8D51-4BA3-9AFB-5B8522138AFDQ35646297-EB114EDE-B822-427D-BDAC-D942FC0618C3Q35720473-31011DDC-8957-4BBE-9C99-2E4903F2B36FQ36085606-4C659FE8-2445-44C1-88FB-76DA58AD292CQ36140437-8BB12E38-02A0-48BA-9DB1-E92D0F443979Q36278698-E8D54BD5-AB3F-4A59-9868-89AFC09F3861Q36414381-9FADADD5-9FEE-4FD7-9BD4-BE1C1E5A16D9Q36563192-02383757-8AC1-4350-B416-6F2C07D9CD62Q36746840-A2B12296-AB4C-47E4-8E82-5004F0DAA7AEQ37426851-833D5E51-DDCB-4FF4-A15D-0C9EFE2A8E6EQ37542835-50B7DDBB-B511-49F3-904E-8DD8C2762434Q38051041-3AC1E8EE-F2DC-49D0-A1A2-8540E9BF8A86Q38081222-71ADEC15-694D-4A35-BDA0-51BF118B9E78Q38213650-7C99B11B-BE98-4D5A-8E49-4D1164BBFCC2Q38774409-1B17C0CD-4919-4E7C-B374-77D270EE8161Q38829063-0F697DE1-E175-4235-A4E1-14EA2A85D74EQ38941385-16561829-7980-411F-9F78-E21C7EF53B2EQ38998999-8683134F-9928-473B-92D9-1CFB1AC9100DQ39172125-A2A8A707-743C-47BA-BF18-305E6C6B9B7DQ39970078-E33923D9-0F34-41DA-9FFF-A1CD3704F99EQ40193700-5E9220E9-AEA0-42ED-B287-4FEED81A7547Q40259741-863AC34F-71B1-4F59-B965-3DD8027891C1Q41493235-D00DD587-4CBA-4128-B15F-790B5FD4B5B7Q41531360-9ECA8D60-6B24-48CC-9700-343732891C48Q42072570-6589BBB1-6931-405B-A282-19939873FD99Q44068120-7C9F06BB-C5C0-48F2-ABF0-F7A0F7E68E20Q44467211-320A4643-85E9-4FCC-AD40-8BC605A856D5Q47160108-DC13C69A-BAAA-4D7B-8359-D4BA71C4E26BQ47715624-589DB221-ECCF-4067-A9D6-040B0D8CEAA9
P2860
The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The current practice of transa ...... nt of hepatocellular carcinoma
@en
The current practice of transa ...... t of hepatocellular carcinoma.
@nl
type
label
The current practice of transa ...... nt of hepatocellular carcinoma
@en
The current practice of transa ...... t of hepatocellular carcinoma.
@nl
prefLabel
The current practice of transa ...... nt of hepatocellular carcinoma
@en
The current practice of transa ...... t of hepatocellular carcinoma.
@nl
P2860
P921
P1476
The current practice of transa ...... nt of hepatocellular carcinoma
@en
P2093
Sung Wook Shin
P2860
P304
P356
10.3348/KJR.2009.10.5.425
P5008
P577
2009-08-25T00:00:00Z